Centro Diagnóstico Boris Berenstein has been acquired by DASA

The Berenstein family has sold Centro Diagnóstico Boris Berenstein (CDBB) to Diagnósticos da America S.A. (DASA).

CDBB is among the most respected and well-known diagnostic imaging services in the Brazilian northeast region, focusing on MRIs, TC scans and ultrasound exams. It has six patient service centers, distributed in four different cities in the Recife metropolitan region.

DASA is one of the leading healthcare companies in Brazil, operating the biggest diagnostics business in LatAm with a nation-wide network of high-complexity hospitals, clinics, oncology centers and other healthcare management services. DASA serves more than 20 million patients every year and has around 40,000 employees and 250,000 hired physicians.

One of Oaklins’ teams in Brazil acted as the exclusive financial advisor to the seller and the management of CDBB in the preparation of the sale process and due diligence, the approach and parallel negotiations with potential buyers, and assisted them until closing.

Service

M&A sell-side

Parties

“The difficult decision-making process to sell the company took a few years, and the choice of the team to lead the negotiation was a very important step for the Berenstein Family. It took a few years of dedication, comings and goings, and a pandemic, but they brought us competence and confidence so that the deal was closed. Congratulations on the excellent work done.”

Boris Berenstein

Former Owner and President, Centro Diagnóstico Boris Berenstein

Talk to the deal team

Denis Salvador Morante

Managing Partner

São Paulo, Brazil
Oaklins Fortezza Partners

View profile Get in touch

Harold Takahashi

Partner

São Paulo, Brazil
Oaklins Fortezza Partners

View profile Get in touch

Related deals

Bayer AG has entered into a takeover agreement with Cara Care

Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

Healthcare

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Learn more

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Healthcare

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Learn more